240 related articles for article (PubMed ID: 14704710)
1. Patent protection for protein structure analysis.
Shimbo I; Nakajima R; Yokoyama S; Sumikura K
Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
[TBL] [Abstract][Full Text] [Related]
2. Patent protection for protein structures and databases.
Meyers TC; Turano TA; Greenhalgh DA; Waller PR
Nat Struct Biol; 2000 Nov; 7 Suppl():950-2. PubMed ID: 11103996
[TBL] [Abstract][Full Text] [Related]
3. Patent threat in emerging economies shifts to biotech.
Jayaranam K
Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
[No Abstract] [Full Text] [Related]
4. In the pursuit of industrial proteomics.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565
[No Abstract] [Full Text] [Related]
5. Patent drop reveals pressures on industry.
Lawrence S
Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
[No Abstract] [Full Text] [Related]
6. Reinventing an industry.
Mandavilli A
Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
[No Abstract] [Full Text] [Related]
7. Recent patent applications in antibodies.
Nat Biotechnol; 2007 Jan; 25(1):58. PubMed ID: 17211397
[No Abstract] [Full Text] [Related]
8. Structural genomics. Tapping DNA for structures produces a trickle.
Service RF
Science; 2002 Nov; 298(5595):948-50. PubMed ID: 12411682
[No Abstract] [Full Text] [Related]
9. The end of the beginning for genomic medicine.
Bailey D; Zanders E; Dean P
Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
[No Abstract] [Full Text] [Related]
10. Recent patent applications in microRNAs.
Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
[No Abstract] [Full Text] [Related]
11. Recent patent applications in angiogenesis research.
Nat Biotechnol; 2006 Feb; 24(2):155. PubMed ID: 16465155
[No Abstract] [Full Text] [Related]
12. [Will genes become an engine to the industry?].
Nylund S; Sibakov M
Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
[No Abstract] [Full Text] [Related]
13. [Structural proteomics and patents].
Sumikura K
Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):967-72. PubMed ID: 12099048
[No Abstract] [Full Text] [Related]
14. The challenge of industrializing proteomics.
Molloy MP
Nat Biotechnol; 2003 Jun; 21(6):597. PubMed ID: 12776137
[No Abstract] [Full Text] [Related]
15. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
16. Data mining.
Nat Biotechnol; 2000 Oct; 18 Suppl():IT35-6. PubMed ID: 11221713
[No Abstract] [Full Text] [Related]
17. Downstream processing of value-added proteins in biotechnology: An Indian scenario.
Babu AK; Vijayalakshmi MA
Biotechnol J; 2009 Aug; 4(8):1132-9. PubMed ID: 19360713
[No Abstract] [Full Text] [Related]
18. Unlocking the money-making potential of RNAi.
Howard K
Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
[No Abstract] [Full Text] [Related]
19. The art of bioprocessing.
Jungbauer A
Biotechnol J; 2006 Feb; 1(2):111. PubMed ID: 16892235
[No Abstract] [Full Text] [Related]
20. How do shotgun proteomics algorithms identify proteins?
Marcotte EM
Nat Biotechnol; 2007 Jul; 25(7):755-7. PubMed ID: 17621303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
